NexgenRx Announces Declaration of Divdends

Core Points - NexgenRx has declared a dividend of $0.005 per share for all outstanding common and series 1 preferred shares [1] - The dividend for common shares will be payable on December 19, 2025, and for series 1 preferred shares on January 1, 2026 [1] - There are 71,117,132 common shares and 6,600,000 series 1 preferred shares outstanding as of the announcement [1] Company Overview - NexgenRx is Canada's only independent full-service Third-Party Administrator and Technology Solutions Provider [2] - The company offers a range of services including eligibility, enrollment, claims adjudication, and provider network coverage through a cost-effective SaaS model [2] - NexgenRx aims to build partnerships with organizations to enhance client and plan member experiences [3]